FREE WEBINAR + LIVE Q&A

A Clinical Update for Chief Medical Officers and Benefits Leaders

The Regenexx Approach:
Dose, Data and Durability

Wed, Oct 14, 2026, 1-2 PM EDT / Fri, Oct 16, 2026, 3-4 PM EDT

Join us for a Regenexx webinar featuring Dr. Chaz Fausel, Chief Medical Officer, and Dr. Matt Murphy, VP of Research and Development. Learn how the Regenexx clinical network provides self-funded employers with a standardized, evidence-based alternative for employees who may otherwise be directed toward orthopedic surgery.

Regenexx Corporate Program Overview

Cut MSK Spend by Up
to 50-70% — Without Surgery

Regenexx helps self-funded employers avoid unnecessary orthopedic procedures and reduce total medical spend by up to 10%.

For Brokers For Employers

Real Employers. Real Results.

“Our 6-month study of Regenexx benefit cases that were all surgically bound have been remarkable. All 8 cases referred to the Regenexx benefit have avoided surgery, recovered extremely well, and returned to work within 7 days or less.”

Andrew L. Davala, Viking Yacht Company

“Dr. Lendermon, looked at my x-rays and said she really was pretty certain that she could really help me. She said a lot of people are told that the next step when you’re bone on bone is a knee replacement and they said, “No, we think we can do better than that. We think we can give you a lot of relief.” She said, “We can’t give you 18 year old knees, but we ought to be able to give you a lot of relief for the next 10 to 15 years.”

Mark V., Clearent by Xplor

“Prior to Regenexx, it was either ‘be in pain’ or ‘get surgery’ and that surgery could affect my lifestyle in that it wasn’t 100% guaranteed and because I’m an active person I was worried that I would be limited physically after fusion surgery. So, while that still might be in my future, Regenexx certainly gave me back my ability to live a lifestyle the way I want to live it.”

Brian M., McGohan Brabender

Transform Orthopedic Care. Improve ROI. Keep Employees Moving.

When conservative care isn’t enough, Regenexx provides a high-quality alternative that helps avoid surgery—and the high costs that come with it.

MSK Continuum of Care

Proven. Scalable. Seamless.

Trusted by 2,000+ employers, Regenexx makes it easy to roll out a non-surgical orthopedic solution that cuts costs and improves outcomes—without disrupting your existing plan.

$100mm total client savings in healthcare spend

2 days average return to work after procedure

1 week average to onboard the Regenexx benefit at no cost to the health plan

Real Members.
Real Results.

Real Members. Real Results.